LGM Pharma Expands U.S. CDMO Capacity and Navigates Reshoring, Supply-Chain Risks

24/7 Biopharma had the opportunity to sit down for a long-form interview about the state of the CDMO industry with Hamilton Lenox, Chief Commercial Officer, and Matt Grazioli, Senior Marketing Manager, of LGM Pharma. The discussion touched on LGM’s recent facility expansions, shifting market demands in the CDMO segment, and how the company is responding to the uncertain state of the global economy, among various other topics.

LATEST VIDEO

Latest news

22nd September 2026

BoomRay Enters Exclusive Global License Agreement with Novartis for a Novel Radioligand Therapy Asset

22nd September 2026

DFE Pharma to showcase its Continuous Manufacturing Platform at CPHI Milan 2026

22nd September 2026

Nanoform’s CESS® technology – a Cost Leader vs Spray-dried Amorphous Solid Dispersions (ASDs)

21st September 2026

Bespak launches next-generation nasal drug product development offering through new collaboration with Upperton

21st September 2026

The Leadership Summit returns for second year at CPHI Milan as pharma confronts a new era of industry transformation

17th September 2026

Quotient Sciences Proprietary AI-Enhanced Solution Optimizes Formulation in Clinical Study

16th September 2026

HAS Group announces Swissmedic approval of Cerbios' expanded Reduced Folates Production Unit

16th September 2026

RSSL launches science-backed consultancy service for pharmaceutical, biopharma and advanced therapy organisations

15th September 2026

CordenPharma Appoints Dr. Jean-Luc Herbeaux as Chief Executive Officer to Lead Next Phase of Growth

15th September 2026

Onyx Scientific backs Sunderland growth with £1.5m facility expansion and new jobs

15th September 2026

Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences

This week’s featured articles

Navigating Complexity: Industry Leaders on Bioprocessing, Manufacturing and Partnership Models

A woman’s view from the HAS Group

Breaking Barriers: Women Scientists Rising to Leadership in Pharma

Strategic Growth in Biologics Manufacturing: Insights from Lonza's Acquisition of the Vacaville Site

Grifols’ supply chain strategy offers lessons beyond saline

Partnered with top industry events and organisations